GT Biopharma, Inc. (GTBP) Financial Statements (2024 and earlier)

Company Profile

Business Address 8000 MARINA BLVD
BRISBANE, CA 94005
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:16,50832,0005,2972860576
Cash and cash equivalents5,6729,2185,2972860576
Short-term investments10,83623,011    
Other undisclosed cash, cash equivalents, and short-term investments (229)    
Prepaid expense  19036424630 
Other undisclosed current assets54(21)    
Total current assets:16,56232,1695,66127490576
Noncurrent Assets
Operating lease, right-of-use asset165   
Property, plant and equipment     356
Intangible assets, net (including goodwill), including:     25,262253,777
Other undisclosed intangible assets, net (including goodwill)     25,262253,777
Deposits noncurrent assets9  12129
Other undisclosed noncurrent assets    110  
Total noncurrent assets:174  12225,309253,792
TOTAL ASSETS:16,73632,1695,66139625,399254,368
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,80910,0908,3776,3483,2172,648
Interest and dividends payable 4,8382,029  
Accounts payable3,1408,1892,2431,9401,7622,546
Accrued liabilities1,6691,9011,2962,3791,455102
Debt  3126,30313,20710,673 
Deferred rent credit     8
Derivative instruments and hedges, liabilities 19138383   
Due to related parties    100 
Other undisclosed current liabilities110 311513131
Total current liabilities:4,93810,25935,09419,70614,0292,679
Noncurrent Liabilities
Liabilities, other than long-term debt 64     
Operating lease, liability 64   
Other undisclosed noncurrent liabilities      
Total noncurrent liabilities:64     
Total liabilities:5,00210,25935,09419,70614,0292,679
Equity
Equity, attributable to parent, including:11,73421,910(29,433)(19,310)11,370251,689
Preferred stock1 3   
Common stock333252705150
Additional paid in capital686,168674,348566,309548,118540,171519,702
Accumulated deficit(674,468)(653,584)(595,628)(567,332)(528,685)(267,896)
Other undisclosed equity, attributable to parent  1,114(169)(166)(167)(167)
Total equity:11,73421,910(29,433)(19,310)11,370251,689
TOTAL LIABILITIES AND EQUITY:16,73632,1695,66139625,399254,368

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues
(gain on Disposition of Assets for Financial Service Operations)
  31,979    
Gross profit:  31,979    
Operating expenses(21,257)(57,515)(6,764)(16,056)(250,069)(135,570)
Other undisclosed operating income (loss)  (31,979)13,528   
Operating income (loss):(21,257)(57,515)6,764(16,056)(250,069)(135,570)
Nonoperating income (expense)373(498)21,532(22,591)(9,117)(7,677)
Investment income, nonoperating   12,598(4,599)(228,515) 
Interest and debt expense31 3,003(2,128)(9,117)(8,602)
Other undisclosed income from continuing operations before equity method investments, income taxes      
Income (loss) from continuing operations before equity method investments, income taxes:(20,853)(58,013)31,299(40,775)(268,303)(151,849)
Other undisclosed income from continuing operations before income taxes    2,1289,1178,602
Income (loss) from continuing operations:(20,853)(58,013)31,299(38,647)(259,186)(143,247)
Income (loss) before gain (loss) on sale of properties:(58,013)31,299(38,647)(259,186)(143,247)
Net income (loss):(20,853)(58,013)31,299(38,647)(259,186)(143,247)
Other undisclosed net loss attributable to parent(31) (59,595)   
Net loss available to common stockholders, diluted:(20,884)(58,013)(28,296)(38,647)(259,186)(143,247)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):(20,853)(58,013)31,299(38,647)(259,186)(143,247)
Comprehensive income (loss), net of tax, attributable to parent:(20,853)(58,013)31,299(38,647)(259,186)(143,247)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: